Lack of awareness and treatment of sudden cardiac arrest (SCA) puts African Americans at greater risk of death from the condition, according to a new national survey released today by the Heart Rhythm Society (HRS). The survey findings uncovered significant perception gaps between healthcare providers and consumers when it comes to understanding the condition, its symptoms, risk factors and treatments. Responsible for more than 350,000 U.S. deaths each year, SCA occurs when the heart suddenly and unexpectedly stops beating. Approximately 95 percent of SCA cases result in death; however, it is proven most deadly in African Americans.
Search for "" returned 25 matches
The meeting will present current and future management on sudden cardiac death, new drug and ablation treatment for atrial fibrillation, pacing and ICD advances, cardiac resynchronization techniques, remote patient monitoring, and advances in neuromodulation for heart failure and hypertension. The well received certificate Cardiac Rhythm Management Course will continue, and new courses on EPS/ECG added.
Members are invited to register for the Scientific Sessions three weeks prior to nonmembers. Submit your application by December 21 to receive a registration invitation before nonmembers are invited to the Sessions.
Application Advanced Mapping and Ablation Technologies (Activity Expired)15264
The session will explore the newer technologies that exist for mapping and ablating some of the common, and less common, substrates that may be treated in the pediatric and adult electrophysiology laboratory.
30 Years Of Ablation (Activity Expired)15265
This session is an historical journey through early DC ablation up to modern electroporative, automatic, and non-thermal ablation techniques, reviewed by a pioneer and expert in the field of interventional electrophysiology.
New Technologies for AF Ablation: Do They Add Value? (Activity Expired)15266
Emphasizing the limitations of current atrial mapping and ablation techniques and where improvement is needed.
Members are invited to register for the Scientific Sessions three weeks prior to nonmembers. Submit your application by December 14 to receive a registration invitation before former Scientific Sessions attendees.
Members are invited to register three weeks prior to nonmembers. Submit your application by December 7 to be considered in time to get the member registration announcement.
Symposium will have two educational sessions and a panel discussion on device guidelines applicable to India. Session 1-Reducing stroke in Atrial Fibrillation and Heart Failure, Session 2-Optimizing technology, health care delivery and practice guidelines in India. There will be an awards ceremony
Physicians who are one or two years out of training can apply for Early Career membership at reduced dues rates.
FHRS eligibility criteria and application for International Electrophysiologists.
FHRS eligibility criteria and application for Scientists and Physician Researchers.
FHRS eligibility criteria and application for pediatric electrophysiologists.
FHRS eligibility criteria and application for Cardiac Surgeons
FHRS eligibility criteria and application for ABIM/AOBIM-certified clinical cardiac electrophysiologists.
In November 2014, the Heart Rhythm Society (HRS) and National Stroke Association, in collaboration with Boehringer Ingelheim (BI), shared results from a survey of more than 1,200 respondents to evaluate the impact of AFib and stroke on patients and caregivers, and the concurrent perceptions physicians have about treatment options and their patients’ understanding of issues surrounding the condition.
June 1, 2016 - This consensus statement provides up-to-date clinical practice guidelines for the use of catheter ablation in children 0–18 years of age with any arrhythmia, and in all patients with congenital heart disease.
August 15, 2016 - IHE is an initiative undertaken by healthcare professionals and industry to facilitate and strengthen the sharing of clinical data among health information technology (IT) systems. Systems developed in accordance with IHE communicate with one another more readily and completely, are easier to implement, and enable care providers to use information more effectively.
Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies23850
May 5, 2011 (Updated August 1, 2011) – Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be life-saving for some patients, the Heart Rhythm Society and the European Heart Rhythm Association have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies. The consensus statement was released at Heart Rhythm 2011, the Heart Rhythm Society’s 32nd Annual Scientific Sessions.
2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction30685
September 14, 2017—The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction, developed in collaboration with the ACC, AHA, APHRS, ASA, EHRA, IDSA, LAHRS, PACES, and STS, is intended to help clinicians in their decision-making process for managing leads and builds on the 2009 Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management document. It provides practical clinical guidance in the broad field of lead management, including lead extraction.
|The document features a clinician summary (an educational derivative product of the full document) and a pocket card, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com to access the pocket card.|
March 9, 2017—Syncope has many causes and clinical presentations; the incidence depends on the population being evaluated. The purpose of this ACC/AHA/HRS guideline is to provide contemporary, accessible, and succinct guidance on the management of adult and pediatric patients with suspected syncope.
The Heart Rhythm Society (HRS) is pleased to announce the launch of the Cardiac Electrophysiology Accreditation program. HRS, in partnership with the Intersocietal Accreditation Commission (IAC), the Pediatric & Congenital Electrophysiology Society (PACES), and the Alliance of Cardiovascular Professionals (ACVP) worked with electrophysiologists and other experts in the field to provide a method by which facilities performing cardiac electrophysiology procedures can document their commitment to quality.
This is the final opportunity to become a member in time to take advantage of the member discount rate for Heart Rhythm 2013. Registration rates increase by up to $100 when the advance registration rate expires. Submit your application early to be considered in time to register before onsite registration rates take effect.
Rates increase by up to $100 when the early registration rate expires. Submit your application early to be considered in time to register before advance registration rates take effect.
November 27, 2017—The 2017 ACC/HRS Lifelong Learning Statement for Clinical Cardiac Electrophysiology Specialists complements the 2015 ACC/AHA/HRS Advanced Training Statement on clinical cardiac electrophysiology by focusing on the competencies expected of practicing cardiac electrophysiologists throughout their careers. It also recognizes those competencies that exceed standard expectations and may be achieved and maintained by some cardiac electrophysiologists based on their specific training and practice focus. This document provides examples of appropriate measures for assessing competence in the context of lifelong learning.